IBDEI027 ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2418,2)
 ;;=^39378
 ;;^UTILITY(U,$J,358.3,2419,0)
 ;;=282.2^^26^183^8
 ;;^UTILITY(U,$J,358.3,2419,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2419,1,1,0)
 ;;=1^282.2
 ;;^UTILITY(U,$J,358.3,2419,1,8,0)
 ;;=8^Anemias d/t Diso of Glutathione
 ;;^UTILITY(U,$J,358.3,2419,2)
 ;;=^7225
 ;;^UTILITY(U,$J,358.3,2420,0)
 ;;=282.3^^26^183^35
 ;;^UTILITY(U,$J,358.3,2420,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2420,1,1,0)
 ;;=1^282.3
 ;;^UTILITY(U,$J,358.3,2420,1,8,0)
 ;;=8^Oth Hemolytic Anemias d/t Enzyme
 ;;^UTILITY(U,$J,358.3,2420,2)
 ;;=^267980
 ;;^UTILITY(U,$J,358.3,2421,0)
 ;;=282.40^^26^183^54
 ;;^UTILITY(U,$J,358.3,2421,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2421,1,1,0)
 ;;=1^282.40
 ;;^UTILITY(U,$J,358.3,2421,1,8,0)
 ;;=8^Thalassemia,Unspec
 ;;^UTILITY(U,$J,358.3,2421,2)
 ;;=^340606
 ;;^UTILITY(U,$J,358.3,2422,0)
 ;;=282.42^^26^183^48
 ;;^UTILITY(U,$J,358.3,2422,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2422,1,1,0)
 ;;=1^282.42
 ;;^UTILITY(U,$J,358.3,2422,1,8,0)
 ;;=8^Sickle-cell Thalassemia w/ Crisis
 ;;^UTILITY(U,$J,358.3,2422,2)
 ;;=^329909
 ;;^UTILITY(U,$J,358.3,2423,0)
 ;;=282.43^^26^183^4
 ;;^UTILITY(U,$J,358.3,2423,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2423,1,1,0)
 ;;=1^282.43
 ;;^UTILITY(U,$J,358.3,2423,1,8,0)
 ;;=8^Alpha Thalessemia
 ;;^UTILITY(U,$J,358.3,2423,2)
 ;;=^340494
 ;;^UTILITY(U,$J,358.3,2424,0)
 ;;=282.44^^26^183^12
 ;;^UTILITY(U,$J,358.3,2424,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2424,1,1,0)
 ;;=1^282.44
 ;;^UTILITY(U,$J,358.3,2424,1,8,0)
 ;;=8^Beta Thalassemia
 ;;^UTILITY(U,$J,358.3,2424,2)
 ;;=^340495
 ;;^UTILITY(U,$J,358.3,2425,0)
 ;;=282.45^^26^183^15
 ;;^UTILITY(U,$J,358.3,2425,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2425,1,1,0)
 ;;=1^282.45
 ;;^UTILITY(U,$J,358.3,2425,1,8,0)
 ;;=8^Delta-beta Thalassemia
 ;;^UTILITY(U,$J,358.3,2425,2)
 ;;=^340496
 ;;^UTILITY(U,$J,358.3,2426,0)
 ;;=282.46^^26^183^53
 ;;^UTILITY(U,$J,358.3,2426,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2426,1,1,0)
 ;;=1^282.46
 ;;^UTILITY(U,$J,358.3,2426,1,8,0)
 ;;=8^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,2426,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,2427,0)
 ;;=282.47^^26^183^19
 ;;^UTILITY(U,$J,358.3,2427,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2427,1,1,0)
 ;;=1^282.47
 ;;^UTILITY(U,$J,358.3,2427,1,8,0)
 ;;=8^Hemoglobin E-beta Thalassemia
 ;;^UTILITY(U,$J,358.3,2427,2)
 ;;=^340498
 ;;^UTILITY(U,$J,358.3,2428,0)
 ;;=282.49^^26^183^42
 ;;^UTILITY(U,$J,358.3,2428,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2428,1,1,0)
 ;;=1^282.49
 ;;^UTILITY(U,$J,358.3,2428,1,8,0)
 ;;=8^Oth Thalassemia
 ;;^UTILITY(U,$J,358.3,2428,2)
 ;;=^329910
 ;;^UTILITY(U,$J,358.3,2429,0)
 ;;=282.5^^26^183^49
 ;;^UTILITY(U,$J,358.3,2429,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2429,1,1,0)
 ;;=1^282.5
 ;;^UTILITY(U,$J,358.3,2429,1,8,0)
 ;;=8^Sickle-cell Trait
 ;;^UTILITY(U,$J,358.3,2429,2)
 ;;=^110419
 ;;^UTILITY(U,$J,358.3,2430,0)
 ;;=282.60^^26^183^47
 ;;^UTILITY(U,$J,358.3,2430,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2430,1,1,0)
 ;;=1^282.60
 ;;^UTILITY(U,$J,358.3,2430,1,8,0)
 ;;=8^Sickle-cell Disease Unspec
 ;;^UTILITY(U,$J,358.3,2430,2)
 ;;=^330077
 ;;^UTILITY(U,$J,358.3,2431,0)
 ;;=282.62^^26^183^17
 ;;^UTILITY(U,$J,358.3,2431,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2431,1,1,0)
 ;;=1^282.62
 ;;^UTILITY(U,$J,358.3,2431,1,8,0)
 ;;=8^Hb-SS Disease w/ Crisis
 ;;^UTILITY(U,$J,358.3,2431,2)
 ;;=^330079
 ;;^UTILITY(U,$J,358.3,2432,0)
 ;;=282.61^^26^183^18
 ;;^UTILITY(U,$J,358.3,2432,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2432,1,1,0)
 ;;=1^282.61
 ;;^UTILITY(U,$J,358.3,2432,1,8,0)
 ;;=8^Hb-SS Disease w/o Crisis
 ;;^UTILITY(U,$J,358.3,2432,2)
 ;;=^330078
 ;;^UTILITY(U,$J,358.3,2433,0)
 ;;=282.63^^26^183^51
 ;;^UTILITY(U,$J,358.3,2433,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2433,1,1,0)
 ;;=1^282.63
 ;;^UTILITY(U,$J,358.3,2433,1,8,0)
 ;;=8^Sickle-cell/Hb-C Dis w/o Crisis
 ;;^UTILITY(U,$J,358.3,2433,2)
 ;;=^330080
 ;;^UTILITY(U,$J,358.3,2434,0)
 ;;=282.64^^26^183^50
 ;;^UTILITY(U,$J,358.3,2434,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2434,1,1,0)
 ;;=1^282.64
 ;;^UTILITY(U,$J,358.3,2434,1,8,0)
 ;;=8^Sickle-cell/Hb-C Dis w/ Crisis
 ;;^UTILITY(U,$J,358.3,2434,2)
 ;;=^329911
 ;;^UTILITY(U,$J,358.3,2435,0)
 ;;=282.68^^26^183^38
 ;;^UTILITY(U,$J,358.3,2435,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2435,1,1,0)
 ;;=1^282.68
 ;;^UTILITY(U,$J,358.3,2435,1,8,0)
 ;;=8^Oth Sickle-cell Dis w/o Crisis
 ;;^UTILITY(U,$J,358.3,2435,2)
 ;;=^329912
 ;;^UTILITY(U,$J,358.3,2436,0)
 ;;=282.69^^26^183^37
 ;;^UTILITY(U,$J,358.3,2436,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2436,1,1,0)
 ;;=1^282.69
 ;;^UTILITY(U,$J,358.3,2436,1,8,0)
 ;;=8^Oth Sickle-cell Dis w/ Crisis
 ;;^UTILITY(U,$J,358.3,2436,2)
 ;;=^330081
 ;;^UTILITY(U,$J,358.3,2437,0)
 ;;=282.7^^26^183^34
 ;;^UTILITY(U,$J,358.3,2437,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2437,1,1,0)
 ;;=1^282.7
 ;;^UTILITY(U,$J,358.3,2437,1,8,0)
 ;;=8^Oth Hemoglobinopathies
 ;;^UTILITY(U,$J,358.3,2437,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,2438,0)
 ;;=282.8^^26^183^40
 ;;^UTILITY(U,$J,358.3,2438,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2438,1,1,0)
 ;;=1^282.8
 ;;^UTILITY(U,$J,358.3,2438,1,8,0)
 ;;=8^Oth Spec Hereditary Hemolytic
 ;;^UTILITY(U,$J,358.3,2438,2)
 ;;=^267984
 ;;^UTILITY(U,$J,358.3,2439,0)
 ;;=283.10^^26^183^31
 ;;^UTILITY(U,$J,358.3,2439,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2439,1,1,0)
 ;;=1^283.10
 ;;^UTILITY(U,$J,358.3,2439,1,8,0)
 ;;=8^Non-autoimmune Hemolytic Anemia
 ;;^UTILITY(U,$J,358.3,2439,2)
 ;;=^294004
 ;;^UTILITY(U,$J,358.3,2440,0)
 ;;=283.11^^26^183^22
 ;;^UTILITY(U,$J,358.3,2440,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2440,1,1,0)
 ;;=1^283.11
 ;;^UTILITY(U,$J,358.3,2440,1,8,0)
 ;;=8^Hemolytic-uremic Syndrome
 ;;^UTILITY(U,$J,358.3,2440,2)
 ;;=^293663
 ;;^UTILITY(U,$J,358.3,2441,0)
 ;;=285.0^^26^183^52
 ;;^UTILITY(U,$J,358.3,2441,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2441,1,1,0)
 ;;=1^285.0
 ;;^UTILITY(U,$J,358.3,2441,1,8,0)
 ;;=8^Sideroblastic Anemia
 ;;^UTILITY(U,$J,358.3,2441,2)
 ;;=^7204
 ;;^UTILITY(U,$J,358.3,2442,0)
 ;;=285.3^^26^183^9
 ;;^UTILITY(U,$J,358.3,2442,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2442,1,1,0)
 ;;=1^285.3
 ;;^UTILITY(U,$J,358.3,2442,1,8,0)
 ;;=8^Antineoplastic Chemo Ind Anemia
 ;;^UTILITY(U,$J,358.3,2442,2)
 ;;=^338232
 ;;^UTILITY(U,$J,358.3,2443,0)
 ;;=285.8^^26^183^39
 ;;^UTILITY(U,$J,358.3,2443,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2443,1,1,0)
 ;;=1^285.8
 ;;^UTILITY(U,$J,358.3,2443,1,8,0)
 ;;=8^Oth Spec Anemia
 ;;^UTILITY(U,$J,358.3,2443,2)
 ;;=^87876
 ;;^UTILITY(U,$J,358.3,2444,0)
 ;;=283.2^^26^183^21
 ;;^UTILITY(U,$J,358.3,2444,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2444,1,1,0)
 ;;=1^283.2
 ;;^UTILITY(U,$J,358.3,2444,1,8,0)
 ;;=8^Hemolytic d/t Hemolysis
 ;;^UTILITY(U,$J,358.3,2444,2)
 ;;=^55770
 ;;^UTILITY(U,$J,358.3,2445,0)
 ;;=280.0^^26^183^27
 ;;^UTILITY(U,$J,358.3,2445,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2445,1,1,0)
 ;;=1^280.0
 ;;^UTILITY(U,$J,358.3,2445,1,8,0)
 ;;=8^Iron Def Anemia,d/t Blood Loss Anemia
 ;;^UTILITY(U,$J,358.3,2445,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,2446,0)
 ;;=280.1^^26^183^28
 ;;^UTILITY(U,$J,358.3,2446,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2446,1,1,0)
 ;;=1^280.1
 ;;^UTILITY(U,$J,358.3,2446,1,8,0)
 ;;=8^Iron Def Anemia,d/t Dietary Intake
 ;;^UTILITY(U,$J,358.3,2446,2)
 ;;=^267972
 ;;^UTILITY(U,$J,358.3,2447,0)
 ;;=280.8^^26^183^26
 ;;^UTILITY(U,$J,358.3,2447,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2447,1,1,0)
 ;;=1^280.8
 ;;^UTILITY(U,$J,358.3,2447,1,8,0)
 ;;=8^Iron Def Anemia,Oth Spec
 ;;^UTILITY(U,$J,358.3,2447,2)
 ;;=^88088
 ;;^UTILITY(U,$J,358.3,2448,0)
 ;;=284.09^^26^183^13
 ;;^UTILITY(U,$J,358.3,2448,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2448,1,1,0)
 ;;=1^284.09
 ;;^UTILITY(U,$J,358.3,2448,1,8,0)
 ;;=8^Constitutional Aplastic Anemia,Oth
 ;;^UTILITY(U,$J,358.3,2448,2)
 ;;=^334036
 ;;^UTILITY(U,$J,358.3,2449,0)
 ;;=286.9^^26^184^9
 ;;^UTILITY(U,$J,358.3,2449,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2449,1,1,0)
 ;;=1^286.9
 ;;^UTILITY(U,$J,358.3,2449,1,8,0)
 ;;=8^Defective Coagulation,Unspec
 ;;^UTILITY(U,$J,358.3,2449,2)
 ;;=^87267
 ;;^UTILITY(U,$J,358.3,2450,0)
 ;;=446.6^^26^184^26
 ;;^UTILITY(U,$J,358.3,2450,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2450,1,1,0)
 ;;=1^446.6
 ;;^UTILITY(U,$J,358.3,2450,1,8,0)
 ;;=8^Thrombotic Microangiopathy
 ;;^UTILITY(U,$J,358.3,2450,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,2451,0)
 ;;=451.9^^26^184^25
 ;;^UTILITY(U,$J,358.3,2451,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2451,1,1,0)
 ;;=1^451.9
 ;;^UTILITY(U,$J,358.3,2451,1,8,0)
 ;;=8^Thrombophlebitis
 ;;^UTILITY(U,$J,358.3,2451,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,2452,0)
 ;;=287.5^^26^184^23
 ;;^UTILITY(U,$J,358.3,2452,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2452,1,1,0)
 ;;=1^287.5
 ;;^UTILITY(U,$J,358.3,2452,1,8,0)
 ;;=8^Thrombocytopenia Nos
 ;;^UTILITY(U,$J,358.3,2452,2)
 ;;=^118988
 ;;^UTILITY(U,$J,358.3,2453,0)
 ;;=287.30^^26^184^21
 ;;^UTILITY(U,$J,358.3,2453,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2453,1,1,0)
 ;;=1^287.30
 ;;^UTILITY(U,$J,358.3,2453,1,8,0)
 ;;=8^Primary Thrombocytopenia (ITP)
 ;;^UTILITY(U,$J,358.3,2453,2)
 ;;=^332841
 ;;^UTILITY(U,$J,358.3,2454,0)
 ;;=238.71^^26^184^24
 ;;^UTILITY(U,$J,358.3,2454,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2454,1,1,0)
 ;;=1^238.71
 ;;^UTILITY(U,$J,358.3,2454,1,8,0)
 ;;=8^Thrombocytosis,Essential
 ;;^UTILITY(U,$J,358.3,2454,2)
 ;;=^334027
 ;;^UTILITY(U,$J,358.3,2455,0)
 ;;=286.53^^26^184^4
 ;;^UTILITY(U,$J,358.3,2455,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2455,1,1,0)
 ;;=1^286.53
 ;;^UTILITY(U,$J,358.3,2455,1,8,0)
 ;;=8^Antiphospholipid w/ Hemor d/o
 ;;^UTILITY(U,$J,358.3,2455,2)
 ;;=^340503
 ;;^UTILITY(U,$J,358.3,2456,0)
 ;;=286.0^^26^184^7
 ;;^UTILITY(U,$J,358.3,2456,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2456,1,1,0)
 ;;=1^286.0
